Nexstim Plc Nexstim Plc: Resolutions of the Extraordinary

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Nexstim Plc Nexstim Plc: Resolutions of the Extraordinary General Meeting of shareholders

Helsinki, 18 August 2016, 15:30 pm

Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or the " Company "), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces the resolutions adopted at its Extraordinary General Meeting of shareholders held today on 18 August.

Backgroud

Nexstim announced on 21 July 2016 (the " Company Announcement ") its plans to strengthen its working and growth capital through a directed share issue of EUR 500,000, a convertible bond facility of EUR 5 million, stand-by equity facilities of EUR 6.5 million and special rights entitling to shares (the " Warrants ") to the Bracknor Investment (" Bracknor ") and to Nexstim's current shareholder, the Finnish Innovation Fund Sitra (" Sitra ", together with Bracknor the " Investors ").

The shares to be issued through the convertible bond facility and the stand-by equity facilities will be subscribed for and the proceeds thereof will be paid to Nexstim over the period of the next 24 months until August 2018 in accordance with the terms and conditions agreed upon by Nexstim separately with both Investors.

In addition to the directed share issue, the convertible bond facility and the stand-by equity facilities, the Warrants entitle the Investors to subscribe for new shares in Nexstim or existing shares in the possession of Nexstim as described in the Company Announcement.

The transaction, including the directed share issue, the convertible bond facility, the stand-by equity facilities and the Warrants (hereinafter the " Transaction "), was conditional on, inter alia, the granting of necessary authorisations by the Extraordinary General Meeting of Nexstim. The Transaction and the agreements, made separately between Nexstim and both Investors, have been described in more detail in the Company Announcement.

Authorisation to the Board of Directors to resolve on issues of shares to Nexstim itself

The Extraordinary General Meeting authorised the Board of Directors to resolve by one or several resolutions on issues of new shares to Nexstim itself without payment for the purpose of the Transaction.

The authorisation consists of up to 15,000,000 shares in the aggregate. The Board of Directors is authorised to resolve on all other terms and conditions of the issues of shares hereunder. The authorisation is effective for five (5) years from the date of the resolution of the Extraordinary General Meeting.

Authorisation to the Board of Directors to resolve on directed share issues

The Extraordinary General Meeting authorised the Board of Directors to resolve by one or several resolutions on issues of new shares or dispose of existing shares in the possession of Nexstim for the purpose of the Transaction.

The aggregate number of new shares to be issued or existing shares in the possession of Nexstim to be disposed of in the directed shares issues shall not exceed 15,000,000 shares, which corresponds to approximately 184.80% of the outstanding shares and votes in Nexstim. Of the maximum number of 15,000,000 shares, a maximum number of 750,000 shares may be issued without payment to Bracknor and Sitra for covering the fees relating to the Transaction and payable by Nexstim.

The Board of Directors is authorised to resolve on all other terms and conditions of the directed share issues. The issues of new shares or the disposals of existing shares in the possession of Nexstim shall be carried out in deviation from the shareholders' pre-emptive rights by way of directed issues. There are especially  weighty financial reasons for deviating from shareholders' pre-emptive subscription rights.

The authorisation is effective for five (5) years from the date of the resolution of the Extraordinary General Meeting. This authorisation does not replace previous authorisations granted to the Board of Directors.

Authorisation to the Board of Directors to resolve on issues of special rights entitling to shares

The Extraordinary General Meeting authorised the Board of Directors to resolve by one or several resolutions on issues of special rights entitling to shares referred to in Chapter 10, Section 1 of the Finnish Companies Act (624/2006, as amended) for the purpose of the convertible bond facility and issues of the Warrants to the Investors.

The aggregate number of new shares to be issued or existing shares in the possession of Nexstim to be disposed of on the basis of special rights entitling to shares shall not exceed 18,000,000 shares, which corresponds to approximately 221.76% of the outstanding shares and votes in Nexstim.

The Board of Directors is authorised to resolve on all other terms and conditions of the issues of special rights entitling to shares. There are especially weighty financial reasons for issuing special rights entitling to shares.

The authorisation is effective for five (5) years from the date of the resolution of the Extraordinary General Meeting. This authorisation does not replace previous authorisations granted to the Board of Directors.

Minutes of the Extraordinary General Meeting

The minutes of the Extraordinary General Meeting will be published on, or by, 1 September 2016, on Nexstim's website.

NEXSTIM PLC Martin Jamieson, CEO

For further information please visit www.nexstim.com or contact:

Nexstim                                                                                                                                  Martin Jamieson, CEO                                                                                     +447715163942                                                                                                 martin.jamieson@nexstim.com

UB Securities Oy (Certified Adviser)                                                          +358 (0)9 2538 0246

Consilium Strategic Communications                                                        +44 (0)20 3709 5700 Mary-Jane Elliott / Ivar Milligan / Laura Thornton                     nexstim@consilium-comms.com

About Nexstim Plc Nexstim is a medical technology company which has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system as the first and only FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation (nTMS) system for pre-surgical mapping of the motor and speech cortices. Based on the same technology platform, the company has developed a system called Navigated Brain Therapy (NBT®) which is CE-marked for chronic neuropathic pain, major depression and stroke therapy. Nexstim's shares are listed on Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit www.nexstim.com

 

HUG#2035599

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 27

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
Arbor Realty Trust Faces Securities Fraud Allegations

Updated Category News Views 33

Securities Lawsuit Against Arbor Realty Trust Looms Well, here we go again. Another day, another securities lawsuit hitting the headlines. This time it's Arbor Realty Trust (NYSE: ABR) getting caught in the crossfire, accused of pulling the wool over investors' eyes. Seems like 'truth in advertising' is just part of the PR playbook for some big shots. Understanding the...

Continue Reading
Xiong'an New Area: People's Priorities Reshape Living Spaces

Updated Category News Views 278

Building a City for the People This here is about prioritizing people over skylines. Xiong'an New Area in Hebei Province is shaping up to be more than just a place on the map; it's an experiment in redefining urban living. Skyscrapers and traffic jams? Not on this menu. Instead, nature paves a graceful dance floor between mid-rise residences. Forget your bustling city...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 14

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading
OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 147

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 202

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Tackling the Industrialized Beast of Insurance Fraud

Updated Category News Views 86

Stepping Up the Fraud Fight This year's emerging fraud trends are taking the term 'organized crime' to new heights, and it's painting a bullseye on the insurance industry. The National Insurance Crime Bureau (NICB) just laid out how fraud isn't just a series of isolated scams anymore—it's an industrial-scale racket. As they spotlight during International Fraud Awareness...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 16

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
Nasdaq Tumbles: AI Hardware Pulls Markets Down

Updated Category News Views 114

Wall Street's Slide Fueled by AI Nerves The markets got a real jolt on Monday, sending Nasdaq down 2.5% thanks to a sharp dip in AI hardware stocks. Tech tickers tied to artificial intelligence were at the core of a sell-off, knocking the S&P 500 down 1.92% alongside it. Investors are on edge, and it’s not just the weather—it's a real shake-up driven by policy moves...

Continue Reading
Operation Healing Forces Partners with Wounded Warrior

Updated Category News Views 80

Joining Forces for Special Operations Families When it comes to the heavy lifting of supporting Special Operations Forces (SOF) families, two powerhouses—Operation Healing Forces (OHF) and Wounded Warrior Project (WWP)—are doubling down. They’re not just tossing around good intentions. Oh no, they’re pulling out the stops with a solid partnership focused on...

Continue Reading

Top 5 Most Recently Viewed Articles

Sotelix Endoscopy Secures $1.7 Million to Innovate Gastro Care

Updated Category News Views 167

Sotelix Endoscopy Secures $1.7 Million in Seed Funding Sotelix Endoscopy, a forward-thinking medical device startup, has recently completed a successful seed round financing, raising an impressive $1.7 million. With this funding, the company will accelerate its research and development of next-generation therapeutic endoscopy devices, which are designed to significantly...

Continue Reading
TriplePoint Venture Growth BDC Faces Market Turbulence

Updated Category News Views 68

Challenges Faced by TriplePoint Venture Growth BDC Corp. In today's ever-shifting market landscape, TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) stock has recently reached a troubling 52-week low, settling at $6.59. This dramatic downturn is the result of investor caution, mirroring a significant 1-year shift of -31.5% in the company's valuation. Specializing in...

Continue Reading
Dave Aronberg Launches New Law Firm, Aims to Make an Impact

Updated Category News Views 349

Dave Aronberg Launches New Law Firm In an exciting new chapter, Dave Aronberg, a well-respected figure in the legal realm, has taken a significant step forward by establishing his own law firm. Having dedicated over two decades as a public servant, Aronberg will now lead a boutique firm specializing in both civil and criminal litigation, as well as land use planning. New...

Continue Reading
2026 Agricultural Outlook: A Dramatic Shift in Farmer Sentiment

Updated Category News Views 163

Shifting Emotions in Agriculture: January 2026 Overview Farmer sentiment has fallen significantly as we step into 2026, reflecting increasing economic anxieties. The recent Ag Economy Barometer, a vital measure of agricultural optimism, showed a considerable drop of 23 points from December to a reading of 113. This downturn points to a growing sense of disillusionment...

Continue Reading
Mattamy Homes Launches Exciting New Community in Goodyear

Updated Category News Views 339

Mattamy Homes Unveils New Community in Goodyear Mattamy Homes proudly announces the grand opening of its latest community, Las Ventanas, in one of the fastest-growing suburban areas. This exciting development offers 18 innovative and unique floor plans designed to meet the needs of modern families. Discover the Las Ventanas Community Las Ventanas represents the commitment...

Continue Reading